Biosensors Intl Grp (BSNRF) 0.7500 $BSNRF
Russia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhvvp7/russia) has announced the addition of the "Russia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Russia Interventional Cardiology Market Outlook to 2020", provides key market data on the Russia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Russia 4 Overview of Key Companies in Russia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/rhvvp7/russia
Mexico Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8plzfx/mexico) has announced the addition of the "Mexico Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Mexico Interventional Cardiology Market Outlook to 2020", provides key market data on the Mexico Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Mexico 4 Overview of Key Companies in Mexico, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Terumo Corporation - Asahi Intecc Co., Ltd. - Volcano Corporation - Cordis Corporation - Merit Medical Systems, Inc. - Biosensors International Group, Ltd. - St. Jude Medical, Inc. For more information visit http://www.researchandmarkets.com/research/8plzfx/mexico
South Korea Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Wed Jun 11, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jt69cf/south_korea) has announced the addition of the "South Korea Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "South Korea Interventional Cardiology Market Outlook to 2020", provides key market data on the South Korea Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, South Korea 4 Overview of Key Companies in South Korea, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Terumo Corporation - Abbott Laboratories - Boston Scientific Corporation - Medtronic, Inc. - amg International GmbH - Cordis Corporation - Volcano Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/jt...outh_korea
Australia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott , Boston Scientific, Medtronic and Cordis
M2 - Wed Jun 11, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2f7zzz/australia) has announced the addition of the "Australia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Australia Interventional Cardiology Market Outlook to 2020", provides key market data on the Australia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Australia 4 Overview of Key Companies in Australia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Terumo Corporation - Volcano Corporation - Asahi Intecc Co., Ltd. - Cordis Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG For more information visit http://www.researchandmarkets.com/research/2f7zzz/australia
Canada Interventional Cardiology Market Outlook 2014-2020
M2 - Fri Jun 06, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wp4wnb/canada) has announced the addition of the "Canada Interventional Cardiology Market Outlook to 2020" report to their offering. "Canada Interventional Cardiology Market Outlook to 2020", provides key market data on the Canada Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for the market category. - Global corporate-level profiles of key companies operating within the Canada Interventional Cardiology market. Key players covered include: - Boston Scientific Corporation - Abbott Laboratories - Medtronic, Inc. - Cordis Corporation - Terumo Corporation - Volcano Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG For more information visit http://www.researchandmarkets.com/research/wp4wnb/canada
EU5 Interventional Cardiology Market Outlook to 2020
M2 - Thu Jun 05, 9:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kg7tl5/eu5) has announced the addition of the "EU5 Interventional Cardiology Market Outlook to 2020" report to their offering. "EU5 Interventional Cardiology Market Outlook to 2020", provides key market data on the EU5 Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Companies Mentioned - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - St. Jude Medical, Inc. - Volcano Corporation - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/kg7tl5/eu5
BRIC Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 05, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz75kt/bric) has announced the addition of the "BRIC Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "BRIC Interventional Cardiology Market Outlook to 2020", provides key market data on the BRIC Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, BRIC 4 Interventional Cardiology Market, Brazil 5 Interventional Cardiology Market, Russia 6 Interventional Cardiology Market, India 7 Interventional Cardiology Market, China 8 Overview of Key Companies in BRIC Interventional Cardiology Market 9 Interventional Cardiology Market Pipeline Products 10 Appendix Companies Mentioned: - Abbott Laboratories - Asahi Intecc - Biosensors International Group - Biotronik SE & Co - Boston Scientific Corporation - Cordis Corporation - Lepu Medical Technology (Beijing) - Medtronic, Inc. - St. Jude Medical, Inc. - Terumo Corporation - Vascular Concepts Limited - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/lz75kt/bric
Spain Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Fri May 30, 4:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7tx53d/spain) has announced the addition of the "Spain Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Spain Interventional Cardiology Market Outlook to 2020", provides key market data on the Spain Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Spain 4 Overview of Key Companies in Spain, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Terumo Corporation - Cordis Corporation - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - St. Jude Medical, Inc. - Asahi Intecc Co., Ltd. - Volcano Corporation - Vascular Concepts Limited For more information visit http://www.researchandmarkets.com/research/7tx53d/spain
Italy Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu May 29, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zm698g/italy) has announced the addition of the "Italy Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Italy Interventional Cardiology Market Outlook to 2020", provides key market data on the Italy Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Italy 4 Overview of Key Companies in Italy, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned: - Abbott Laboratories - Medtronic, Inc. - Boston Scientific Corporation - Terumo Corporation - Cordis Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/zm698g/italy
Germany Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic, and Cordis
M2 - Thu May 29, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lq94nj/germany) has announced the addition of the "Germany Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Germany Interventional Cardiology Market Outlook to 2020", provides key market data on the Germany Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Germany 4 Overview of Key Companies in Germany, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned: - Abbott Laboratories - Asahi Intecc Co., Ltd. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - Boston Scientific Corporation - Cordis Corporation - Medtronic, Inc. - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/lq94nj/germany
France Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu May 29, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zmfcr8/france) has announced the addition of the "France Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "France Interventional Cardiology Market Outlook to 2020", provides key market data on the France Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, France 4 Overview of Key Companies in France, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Abbott Laboratories - Asahi Intecc Co., Ltd. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - Boston Scientific Corporation - Cordis Corporation - Medtronic, Inc. - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/zmfcr8/france
Biosensors Reports Financial Results for Fiscal Year 2014
PR Newswire - Wed May 28, 7:10AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its fourth fiscal quarter ("Q4 FY14"
and fiscal full year ended 31 March 2014 ("FY14" .
Biosensors Announces Appointment of New CEO
PR Newswire - Wed May 28, 7:04AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced that Mr. Jose ("Pepe" Calle Gordo has been appointed the Company's new Chief Executive Officer (CEO), with effect from 1st November 2014. Dr. Jack Wang will continue with the company to help the transition and take on a new role of Chief Technology Officer. Meanwhile, Mr. Yoh-Chie Lu, Biosensors' Executive Chairman, will serve as interim CEO during this transitional period.
Germany Cardiovascular Devices Market Outlook Report 2014-2020
M2 - Wed May 28, 4:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9glc9f/germany) has announced the addition of the "Germany Cardiovascular Devices Market Outlook Report 2014-2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Devices market wherever available. "Germany Cardiovascular Devices Market Outlook to 2020", provides key market data on the Germany Cardiovascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Cardiac Assist Devices - Cardiac Rhythm Management Devices - Cardiovascular Monitoring and Diagnostic Devices - Cardiovascular Prosthetic Devices - Cardiovascular Surgery Devices - Electrophysiology Devices - External Defibrillators - Interventional Cardiology - Peripheral Vascular Devices Prosthetic Heart Valves. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Germany Cardiovascular Devices market. Key players covered include: - Medtronic, Inc. - Boston Scientific Corporation - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Abbott Laboratories - Edwards Lifesciences Corporation - Sorin S.p.A. - Cordis Corporation - Terumo Corporation - Biosense Webster, Inc. - HeartWare International, Inc. - Philips Healthcare - Maquet Holding B.V. & Co. KG. - Covidien plc - Biosensors International Group, Ltd. For more information visit http://www.researchandmarkets.com/research/9glc9f/germany
China Cardiovascular Devices Market Outlook 2014-2020
M2 - Tue May 27, 6:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/whdjsf/china) has announced the addition of the "China Cardiovascular Devices Market Outlook to 2020" report to their offering. "China Cardiovascular Devices Market Outlook to 2020", provides key market data on the China Cardiovascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Devices market wherever available. Scope - Market size and company share data for Cardiovascular Devices categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. - Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the China Cardiovascular Devices market. Key players covered include: - Medtronic, Inc. - Lepu Medical Technology (Beijing) Co., Ltd. - Boston Scientific Corporation - Terumo Corporation - St. Jude Medical, Inc. - Abbott Laboratories - Biosensors International Group, Ltd. - Edwards Lifesciences Corporation - Cordis Corporation - Asahi Intecc Co., Ltd. - Biotronik SE & Co. KG - Sorin S.p.A. - Volcano Corporation - Covidien plc - Biosense Webster, Inc. - C. R. Bard, Inc. - Lifetech Scientific (Shenzhen) Co., Ltd. - Philips Healthcare - Maquet Holding B.V. & Co. KG. For more information visit http://www.researchandmarkets.com/research/whdjsf/china
Biosensors Announces IDE Approval for BioFreedom(TM) U.S. Trial
PR Newswire - Mon May 05, 7:02AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced today that the U.S. Food and Drug Administration (FDA) recently granted conditional Investigational Device Exemption (IDE) approval for a U.S.-based clinical trial of the BioFreedom(TM) polymer-free drug-coated stent (DCS) system.
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2014
PR Newswire - Wed Feb 12, 7:01AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2014 ("Q3 FY14" and nine months ended 31 December 2013 ("FY14 nine-month period" .
Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional
PR Newswire - Fri Feb 07, 4:41PM CST
/Continental Who's Who/ -- Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as Gynecologist with Melbourne Internal Medicine Associates.
Associated Announces Dividends
PR Newswire - Tue Jan 28, 3:05PM CST
The Board of Directors of Associated Banc-Corp (NASDAQ:ASBC) today declared a regular quarterly cash dividend of $0.09 per common share, payable on March 17, 2014, to shareholders of record at the close of business on March 3, 2014.
Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2014
PR Newswire - Wed Aug 07, 8:36AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its fiscal first quarter ended 30 June 2013 (Q1 FY14).
Russia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhvvp7/russia) has announced the addition of the "Russia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Russia Interventional Cardiology Market Outlook to 2020", provides key market data on the Russia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Russia 4 Overview of Key Companies in Russia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/rhvvp7/russia
Mexico Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8plzfx/mexico) has announced the addition of the "Mexico Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Mexico Interventional Cardiology Market Outlook to 2020", provides key market data on the Mexico Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Mexico 4 Overview of Key Companies in Mexico, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Terumo Corporation - Asahi Intecc Co., Ltd. - Volcano Corporation - Cordis Corporation - Merit Medical Systems, Inc. - Biosensors International Group, Ltd. - St. Jude Medical, Inc. For more information visit http://www.researchandmarkets.com/research/8plzfx/mexico
South Korea Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Wed Jun 11, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jt69cf/south_korea) has announced the addition of the "South Korea Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "South Korea Interventional Cardiology Market Outlook to 2020", provides key market data on the South Korea Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, South Korea 4 Overview of Key Companies in South Korea, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Terumo Corporation - Abbott Laboratories - Boston Scientific Corporation - Medtronic, Inc. - amg International GmbH - Cordis Corporation - Volcano Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/jt...outh_korea
Australia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott , Boston Scientific, Medtronic and Cordis
M2 - Wed Jun 11, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2f7zzz/australia) has announced the addition of the "Australia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Australia Interventional Cardiology Market Outlook to 2020", provides key market data on the Australia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Australia 4 Overview of Key Companies in Australia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Terumo Corporation - Volcano Corporation - Asahi Intecc Co., Ltd. - Cordis Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG For more information visit http://www.researchandmarkets.com/research/2f7zzz/australia
Canada Interventional Cardiology Market Outlook 2014-2020
M2 - Fri Jun 06, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wp4wnb/canada) has announced the addition of the "Canada Interventional Cardiology Market Outlook to 2020" report to their offering. "Canada Interventional Cardiology Market Outlook to 2020", provides key market data on the Canada Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for the market category. - Global corporate-level profiles of key companies operating within the Canada Interventional Cardiology market. Key players covered include: - Boston Scientific Corporation - Abbott Laboratories - Medtronic, Inc. - Cordis Corporation - Terumo Corporation - Volcano Corporation - St. Jude Medical, Inc. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG For more information visit http://www.researchandmarkets.com/research/wp4wnb/canada
EU5 Interventional Cardiology Market Outlook to 2020
M2 - Thu Jun 05, 9:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kg7tl5/eu5) has announced the addition of the "EU5 Interventional Cardiology Market Outlook to 2020" report to their offering. "EU5 Interventional Cardiology Market Outlook to 2020", provides key market data on the EU5 Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Companies Mentioned - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - St. Jude Medical, Inc. - Volcano Corporation - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/kg7tl5/eu5
BRIC Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 05, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz75kt/bric) has announced the addition of the "BRIC Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "BRIC Interventional Cardiology Market Outlook to 2020", provides key market data on the BRIC Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, BRIC 4 Interventional Cardiology Market, Brazil 5 Interventional Cardiology Market, Russia 6 Interventional Cardiology Market, India 7 Interventional Cardiology Market, China 8 Overview of Key Companies in BRIC Interventional Cardiology Market 9 Interventional Cardiology Market Pipeline Products 10 Appendix Companies Mentioned: - Abbott Laboratories - Asahi Intecc - Biosensors International Group - Biotronik SE & Co - Boston Scientific Corporation - Cordis Corporation - Lepu Medical Technology (Beijing) - Medtronic, Inc. - St. Jude Medical, Inc. - Terumo Corporation - Vascular Concepts Limited - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/lz75kt/bric
Spain Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Fri May 30, 4:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7tx53d/spain) has announced the addition of the "Spain Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Spain Interventional Cardiology Market Outlook to 2020", provides key market data on the Spain Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Spain 4 Overview of Key Companies in Spain, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Abbott Laboratories - Boston Scientific Corporation - Terumo Corporation - Cordis Corporation - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - St. Jude Medical, Inc. - Asahi Intecc Co., Ltd. - Volcano Corporation - Vascular Concepts Limited For more information visit http://www.researchandmarkets.com/research/7tx53d/spain
Italy Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu May 29, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zm698g/italy) has announced the addition of the "Italy Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Italy Interventional Cardiology Market Outlook to 2020", provides key market data on the Italy Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Italy 4 Overview of Key Companies in Italy, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned: - Abbott Laboratories - Medtronic, Inc. - Boston Scientific Corporation - Terumo Corporation - Cordis Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation - Asahi Intecc Co., Ltd. For more information visit http://www.researchandmarkets.com/research/zm698g/italy
Germany Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic, and Cordis
M2 - Thu May 29, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lq94nj/germany) has announced the addition of the "Germany Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Germany Interventional Cardiology Market Outlook to 2020", provides key market data on the Germany Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Germany 4 Overview of Key Companies in Germany, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned: - Abbott Laboratories - Asahi Intecc Co., Ltd. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - Boston Scientific Corporation - Cordis Corporation - Medtronic, Inc. - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/lq94nj/germany
France Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu May 29, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zmfcr8/france) has announced the addition of the "France Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "France Interventional Cardiology Market Outlook to 2020", provides key market data on the France Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, France 4 Overview of Key Companies in France, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Abbott Laboratories - Asahi Intecc Co., Ltd. - Biosensors International Group, Ltd. - Biotronik SE & Co. KG - Boston Scientific Corporation - Cordis Corporation - Medtronic, Inc. - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/zmfcr8/france
Biosensors Reports Financial Results for Fiscal Year 2014
PR Newswire - Wed May 28, 7:10AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its fourth fiscal quarter ("Q4 FY14"
and fiscal full year ended 31 March 2014 ("FY14" . Biosensors Announces Appointment of New CEO
PR Newswire - Wed May 28, 7:04AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced that Mr. Jose ("Pepe"
Calle Gordo has been appointed the Company's new Chief Executive Officer (CEO), with effect from 1st November 2014. Dr. Jack Wang will continue with the company to help the transition and take on a new role of Chief Technology Officer. Meanwhile, Mr. Yoh-Chie Lu, Biosensors' Executive Chairman, will serve as interim CEO during this transitional period. Germany Cardiovascular Devices Market Outlook Report 2014-2020
M2 - Wed May 28, 4:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9glc9f/germany) has announced the addition of the "Germany Cardiovascular Devices Market Outlook Report 2014-2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Devices market wherever available. "Germany Cardiovascular Devices Market Outlook to 2020", provides key market data on the Germany Cardiovascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Cardiac Assist Devices - Cardiac Rhythm Management Devices - Cardiovascular Monitoring and Diagnostic Devices - Cardiovascular Prosthetic Devices - Cardiovascular Surgery Devices - Electrophysiology Devices - External Defibrillators - Interventional Cardiology - Peripheral Vascular Devices Prosthetic Heart Valves. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Germany Cardiovascular Devices market. Key players covered include: - Medtronic, Inc. - Boston Scientific Corporation - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Abbott Laboratories - Edwards Lifesciences Corporation - Sorin S.p.A. - Cordis Corporation - Terumo Corporation - Biosense Webster, Inc. - HeartWare International, Inc. - Philips Healthcare - Maquet Holding B.V. & Co. KG. - Covidien plc - Biosensors International Group, Ltd. For more information visit http://www.researchandmarkets.com/research/9glc9f/germany
China Cardiovascular Devices Market Outlook 2014-2020
M2 - Tue May 27, 6:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/whdjsf/china) has announced the addition of the "China Cardiovascular Devices Market Outlook to 2020" report to their offering. "China Cardiovascular Devices Market Outlook to 2020", provides key market data on the China Cardiovascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Devices market wherever available. Scope - Market size and company share data for Cardiovascular Devices categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. - Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the China Cardiovascular Devices market. Key players covered include: - Medtronic, Inc. - Lepu Medical Technology (Beijing) Co., Ltd. - Boston Scientific Corporation - Terumo Corporation - St. Jude Medical, Inc. - Abbott Laboratories - Biosensors International Group, Ltd. - Edwards Lifesciences Corporation - Cordis Corporation - Asahi Intecc Co., Ltd. - Biotronik SE & Co. KG - Sorin S.p.A. - Volcano Corporation - Covidien plc - Biosense Webster, Inc. - C. R. Bard, Inc. - Lifetech Scientific (Shenzhen) Co., Ltd. - Philips Healthcare - Maquet Holding B.V. & Co. KG. For more information visit http://www.researchandmarkets.com/research/whdjsf/china
Biosensors Announces IDE Approval for BioFreedom(TM) U.S. Trial
PR Newswire - Mon May 05, 7:02AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced today that the U.S. Food and Drug Administration (FDA) recently granted conditional Investigational Device Exemption (IDE) approval for a U.S.-based clinical trial of the BioFreedom(TM) polymer-free drug-coated stent (DCS) system.
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2014
PR Newswire - Wed Feb 12, 7:01AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2014 ("Q3 FY14"
and nine months ended 31 December 2013 ("FY14 nine-month period" . Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional
PR Newswire - Fri Feb 07, 4:41PM CST
/Continental Who's Who/ -- Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as Gynecologist with Melbourne Internal Medicine Associates.
Associated Announces Dividends
PR Newswire - Tue Jan 28, 3:05PM CST
The Board of Directors of Associated Banc-Corp (NASDAQ:ASBC) today declared a regular quarterly cash dividend of $0.09 per common share, payable on March 17, 2014, to shareholders of record at the close of business on March 3, 2014.
Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2014
PR Newswire - Wed Aug 07, 8:36AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its fiscal first quarter ended 30 June 2013 (Q1 FY14).
